| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 107.562 | - | - | 134.803 | 134.441 | 112.485 | 135.433 | 177.085 | 189.360 | 220.700 |
| Total Income - EUR | 107.572 | - | - | 134.812 | 134.447 | 112.485 | 136.771 | 177.088 | 190.007 | 231.031 |
| Total Expenses - EUR | 70.678 | - | - | 96.718 | 108.695 | 105.974 | 130.010 | 172.776 | 197.115 | 221.391 |
| Gross Profit/Loss - EUR | 36.894 | - | - | 38.095 | 25.752 | 6.512 | 6.761 | 4.311 | -7.109 | 9.640 |
| Net Profit/Loss - EUR | 33.664 | - | - | 36.747 | 24.407 | 5.387 | 5.388 | 2.735 | -8.983 | 2.649 |
| Employees | 5 | - | - | 6 | 0 | 0 | 4 | 4 | 5 | 5 |
Check the financial reports for the company - Biohem Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 51.937 | - | - | 52.221 | 52.459 | 76.279 | 98.153 | 79.712 | 61.626 | 68.363 |
| Current Assets | 48.815 | - | - | 34.674 | 42.933 | 23.499 | 16.560 | 32.682 | 40.868 | 32.419 |
| Inventories | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.043 | - | - | 30.151 | 10.189 | 2.740 | 3.607 | 12.287 | 10.559 | 2.231 |
| Cash | 29.772 | - | - | 4.523 | 32.743 | 20.760 | 12.953 | 20.395 | 30.310 | 30.188 |
| Shareholders Funds | 76.263 | - | - | 75.926 | 90.784 | 94.449 | 97.743 | 100.782 | 83.377 | 85.560 |
| Social Capital | 225 | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 25.888 | - | - | 10.969 | 4.608 | 5.329 | 16.969 | 11.612 | 19.118 | 15.221 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Biohem Srl